The immunobiology of myelodysplastic neoplasms: a mini-review

This mini review summarizes the immunobiology of myelodysplastic syndromes, specifically focusing on the interactions between immune cells, cytokines, and dysplastic cells within the tumor microenvironment in the bone marrow. We elucidate in detail how immune dysregulation and evasion influence the...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 15; p. 1419807
Main Authors Kannan, Shruthi, Vedia, Rolando A, Molldrem, Jeffrey J
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 16.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This mini review summarizes the immunobiology of myelodysplastic syndromes, specifically focusing on the interactions between immune cells, cytokines, and dysplastic cells within the tumor microenvironment in the bone marrow. We elucidate in detail how immune dysregulation and evasion influence the initiation and progression of myelodysplastic syndromes, as well as resistance to therapy and progression to AML. In addition, we highlight a range of therapeutic strategies, including the most recent breakthroughs and experimental therapies for treating MDS. Finally, we address the existing knowledge gaps in the understanding of the immunobiology of MDS and propose future research directions, promising advancements toward enhancing clinical outcomes and survival for patients with MDS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Vadim V. Sumbayev, University of Kent, United Kingdom
Edited by: Shyam Patel, University of Massachusetts Medical School, United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1419807